1. Canada Stocks

  2. •

    Process industries

  3. •

    Agricultural commodities/Milling
Britannia Life Sciences Inc

Britannia Life Sciences Inc

0.07
CAD
+0.01
(+7.69%)
0.09EPS
0.74P/E
12.34MMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.02
0.07
0.04
- -
- -
- -
- -
Basic EPS, GAAP
- -
-0.14
0.03
-0.03
0.05
0.09
0.1
Free Cash Flow per Basic Share
-0.01
0.02
0.01
0.01
-0.02
-0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
0.01
0.04
0.02
0.04
0.13
0.13
Tangible Book Value per Share
-0.24
-0.1
-0.07
-0.1
0.04
0.13
0.13
Basic Weighted Avg Shares
78
110
162
162
162
162
162
Sales/Revenue/Turnover
1
7
6
1
- -
- -
- -
Operating Margin (%)
19.83
-114.47
15.52
-1,320.32
-548.2
-306.82
-348.35
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-15
5
-5
7
15
17
Effective Tax Rate (%)
64.31
- -
0.34
- -
- -
3.74
3.28
Profit Margin (%)
-11.03
-211.76
79.39
-922.51
2,001.95
3,085.51
4,069.61
Working Capital
-8
-5
- -
-8
6
16
12
LT Debt
3
- -
6
5
2
- -
- -
Total Equity
3
5
11
7
6
21
22
Return on Invested Capital (%)
- -
- -
1.18
- -
- -
-9.69
-9.53
Return on Capital (%)
- -
- -
34.37
- -
- -
100.73
111.78
Return on Common Equity (%)
- -
- -
121.4
-100.79
169.2
108.33
119.87

Capital Structure

CAD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
162
162
165
Market Capitalization
15
15
12

Working Capital

CAD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
17
19
14
Cash, Cash Equivalents & STI
16
17
12
Accounts Receivable, Net
1
1
2
Inventories
- -
- -
- -
Total Current Liabilities
5
3
3
Payables & Accruals
5
3
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
78.35%
229.31%
Free Cash Flow
- -
-180.17%
-55.86%
Net Income, GAAP
- -
1,850.47%
98.18%
Sales/Revenue/Turnover
- -
61.65%
28.58%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
-5
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
-0.01
- -
0.06
0.05
2026
- -
- -
0.07
0.02
0.09
2027
0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Peter James Shippen
Full Time Employees
28
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
120 Adelaide Street West Toronto ON Canada M5H 1T1
IPO Date
Dec 1, 2017
Website
britannia.life
Similar Companies
Patanjali Foods Limited (NSE:PATANJALI)
Tilray Brands, Inc. (NASDAQ:TLRY)
Archer-Daniels-Midland Company (NYSE:ADM)
Corteva, Inc. (NYSE:CTVA)
Balrampur Chini Mills Ltd (NSE:BALRAMCHIN)
Canopy Growth Corporation (NASDAQ:CGC)
Business
Britannia Life Sciences Inc. Britannia Life Sciences Inc. (CSE:BLAB) operates as a diversified services platform providing laboratory support, product development, testing, safety assessment, analytical and microbiological services, global compliance, and consumer evaluations primarily to clients in the cosmetics, consumer packaged goods, food and beverage, nutraceutical, household goods, and wellness industries; it offers specialized expertise in topical and edible cannabis products including novel food authorizations, as well as geochemical testing and PhotonAssay technology through its subsidiary Britannia Mining Solutions Inc. for the natural resources sector. The company maintains an ISO 17025 accredited laboratory and serves multinational corporations, retailers, brands, and startups across North America, Europe, the United Kingdom, and international markets, with headquarters in Toronto, Ontario, Canada. Founded through a 2021 reverse takeover and historically focused on science-based services, Britannia Life Sciences recently divests its UK laboratory and testing business to a private acquiror for up to CAD$43.6 million in enterprise value and enters a $11.3 million share exchange agreement with McEwen Inc. and Britannia Mining Solutions Inc. (dba Paragon Geochemical Laboratories Inc.), crystallizing value in its mining analytical services portfolio while repositioning toward private debt, non-resource royalties, and potential rebranding beyond life sciences.

Company News

Company News APIChatGPT